MDM2 antibody (pThr218)
Quick Overview for MDM2 antibody (pThr218) (ABIN3031737)
Target
See all MDM2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pThr218
-
Purification
- Antigen affinity purified
-
Immunogen
- This p-MDM2 antibody was produced from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding pT218 of human MDM2.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the p-MDM2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Dot blot: 1:500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS pH 7.4 with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the p-MDM2 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- MDM2 (Mdm2, p53 E3 Ubiquitin Protein Ligase Homolog (Mouse) (MDM2))
-
Alternative Name
- MDM2
-
Background
- MDM2 is a target of the transcription factor tumor protein p53. The encoded protein is a nuclear phosphoprotein that binds and inhibits transactivation by tumor protein p53, as part of an autoregulatory negative feedback loop. Overexpression of MDM2 can result in excessive inactivation of tumor protein p53, diminishing its tumor suppressor function. This protein has E3 ubiquitin ligase activity, which targets tumor protein p53 for proteasomal degradation. This protein also affects the cell cycle,apoptosis, and tumorigenesis through interactions with other proteins, including retinoblastoma 1 and ribosomal protein L5.
-
UniProt
- Q00987
-
Pathways
- p53 Signaling, PI3K-Akt Signaling, Cell Division Cycle, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Autophagy, Ubiquitin Proteasome Pathway
Target
-